5Green A I, Patel J K, Goisman R M, et al. Weight gain from novel antipsychotic drugs: need for action[J]. Gen Hosp Psychiatry,2000,22(4) :224- 235.
6Robinson D G, Woerner M G, Delman H M, et al. Phar macological treatments for first-episode schizophrenia[J]. Schizophr Bull, 2005,31 (3) : 705-722.
7Bobes J, Arango C, Aranda P, et al. Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics., results of the CLAMORS Study [J]. Schizophr Res,2007,90(1-3):162- 173.
8Herva A, Laitinen J, Miettunen J, et al. Obesity and de- pression: results from the longitudinal Northern Finland 1966 Birth Cohort Study[J]. Int J Obes (Lond) ,2006,30 (3) :520-527.
9Berkowitz R I, Fabricatore A N. Obesity, psychiatric status, and psychiatric medications[J]. Psychiatr Clin North Am,2005,28(1) :39-54.
10Weiden P J, Mackell J A, McDonnell D D. Obesity as a risk factor for antipsychotic noncompliance[J]. Schizophr Res,2004,66(1) :51-57.
